[1] Lu Y, Liu Q, Lu T, et al. Clinicopathological features of follicular dendritic cell sarcoma. Acta academiae medicinae sinicae. 2020; 42(2): 504-512.
[2] Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press. 2008: 323.
[3] Zhang T, He L, Wang ZH, et al. Follicular dendritic cell sarcoma presenting as a thyroid mass: an unusual case report and literature review. Journal of International Medical Research. 2020; 48(6): 1-9.
[4] Qu C, Tian XD, Ma YS, et al. Multidisciplinary diagnosis and treatment of recurrent follicular dendritic cell sarcoma in abdomen: a case report.Medicine. 2020; 99(51): e23588.
[5] Shen SC, Wu CC, Ng KF, et al. Follicular dendritic cell sarcoma mimicking giant cell carcinoma of the pancreas. Pathology international. 2006; 56(8): 466-470.
[6] Lu T, Song B, Pu H, et al. Paraneoplastic pemphigus and myasthenia gravis as the first manifestations of a rare case of pancreatic follicular dendritic cell sarcoma:CT findings and review of literature. BMC gastroenterology. 2019; 19(1): 92.
[7] Madison M, Michael SS, David TL, et al. Pancreatic inflammatory pseudotumor-like follicular dendritic cell tumor. Case reports in pathology. 2019; (2): 1-5.
[8] Liang WJ, He W, Li ZW, et al. Extranodal follicular dendritic cell sarcoma originating in the pancreas: a case report. Medicine. 2016; 95(15): e3377.
[9] Masaoki S, Hiroaki I, Takaaki Y, et al. Follicular dendritic cell sarcoma treated with a variety of chemotherapy. Hematological Oncology. 2017; 35(4): 905-908.
[10] Wu A, Pullarkat S. Follicular dendritic cell carcoma. Archives of Pathology & Laboratory Medicine. 2016; 140(2): 186-190.
[11] Saygin C, Uzunaslan D, Ozguroglu M, et al. Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series. Critical Reviews in Oncology Hematology. 2013; 88(2): 253-271.
[12] Mao SY, Dong J, Wang YQ, et al. Follicular dendritic cell sarcomas: CT and MRI findings in 20 patients. American Journal of Roentgenology. 2021; 216(3): 835-843.
[13] Asiry S, Khader SN, Villanueva-Siles E, et al. Follicular dendritic cell sarcoma: cytomorphologic features and diagnostic challenges. Diagnostic cytopathology. 2021; 49(3): 457-461.
[14] Chan JK, Fletcher CD, Nayler SJ, et al. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer. 1997; 79(2): 294-313.
[15] De Pas T, Spitaleri G, Pruneri G, et al. Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases. Critical reviews in oncology hematology. 2008; 65(1): 1-7.
[16] Finn LS, Viswanatha DS, Belasco JB, et al. Primary follicular lymphoma of the testis in childhood. Cancer. 1999; 85(7): 1626-1635.
[17] Choi BS, Baek JH, Shin YM, et al. Follicular dendritic cell sarcoma: a case report and review of the literature. Cancer research and treatment. 2010; 42(2): 121-124.
[18] Shinagare AB, Ramaiya NH, Jagannathan JP, et al. Primary follicular dendritic cell sarcoma of liver treated with cyclophosphamide, doxorubicin, vincristine, and prednisone regimen and surgery. Journal of clinical oncology. 2011; 29(35): e849-851.
[19] Vacirca JL, Acs PI, Tabbara IA, et al. Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma. Annals of hematology. 2014; 93(3):403–409.
[20] Agaimy A, Michal M, Hadravsky L, et al. Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1. Annals of diagnostic pathology. 2016; 23: 21-28.
[21] Laginestra MA, Tripodo C, Agostinelli C, et al. Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of follicular dendritic cell sarcomas. Molecular cancer research. 2017; 15(5): 541-552.
[22] Lee MY, Bernabe-Ramirez C, Ramirez DC, et al. Follicular dendritic cell sarcoma and its response to immune checkpoint inhibitors nivolumab and ipilimumab. BMJ case reports. 2020; 13(4): 2019.